Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

NKAIN2 Activators

Chemical activators of NKAIN2 play a pivotal role in modulating its activity through various intracellular signaling pathways. PIP2, as a substrate for the phospholipase C (PLC) pathway, can activate NKAIN2 by initiating the hydrolysis of PIP2 to IP3, which in turn triggers the release of calcium ions from the endoplasmic reticulum. This increase in intracellular calcium concentration is a signal for various calcium-sensitive proteins, which includes NKAIN2, to become active. Similarly, the calcium ionophore ionomycin raises the intracellular calcium level, thereby enhancing the activity of these calcium-dependent proteins. Thapsigargin also contributes to the rise in cytosolic calcium by inhibiting the SERCA pump, indirectly influencing NKAIN2 activity. Furthermore, calmodulin, upon binding with calcium, undergoes a conformational change allowing it to interact with and activate different kinase enzymes.

Other chemicals exert their influence on NKAIN2 through different mechanisms. For example, phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C (PKC), which then phosphorylates a variety of substrates, potentially including NKAIN2. Forskolin, by activating adenylyl cyclase, enhances the levels of cAMP, which in turn activates PKA that can phosphorylate NKAIN2. Okadaic Acid, an inhibitor of protein phosphatases PP1 and PP2A, indirectly contributes to increased phosphorylation levels of proteins within the cell, affecting NKAIN2 activity. Anisomycin and epidermal growth factor (EGF) both activate MAPK signaling pathways, which often culminate in the phosphorylation of NKAIN2. Bisindolylmaleimide I and SB 203580, through their inhibitory effects on PKC and p38 MAP kinase respectively, may lead to the compensatory activation of other kinases that also target NKAIN2, resulting in its enhanced activity. These diverse chemicals, through their unique interactions with cellular enzymes and signaling pathways, contribute to the regulation of NKAIN2 activity within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Calmodulin (human), (recombinant)

73298-54-1sc-471287
1 mg
$300.00
(0)

Calmodulin, upon binding calcium, undergoes a conformational change that allows it to activate various kinase enzymes including those that would phosphorylate and thereby activate NKAIN2 as part of calcium-dependent signaling pathways.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates Protein Kinase C (PKC) which is known to phosphorylate a wide range of substrates, including potentially NKAIN2, as part of the PKC signaling pathway where NKAIN2 is implicated.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin acts as an ionophore that increases intracellular calcium concentration, thus activating calcium-sensitive proteins including potential kinases that phosphorylate and activate NKAIN2.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the SERCA pump, leading to an increase in cytosolic calcium levels, which activates calcium-dependent proteins that could phosphorylate and activate NKAIN2.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of proteins within various signaling pathways, potentially including NKAIN2, resulting in its activation.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin activates MAPK signaling pathways by acting as a protein synthesis inhibitor, which can lead to the phosphorylation and activation of NKAIN2 within these pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 is a specific inhibitor of p38 MAP kinase and its inhibition can lead to compensatory activation of related kinases within the MAPK pathway, which could phosphorylate and activate NKAIN2.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I specifically inhibits PKC, which may lead to compensatory activation of other kinases that could phosphorylate and activate NKAIN2 in an effort to maintain cellular homeostasis.